Case report: The combined use of amantadine and l-dopa/ carbidopa in the treatment of chronic brain injury

References

• INTERAGENCY HEAD INJURY TASK FORCE: Report, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD February 1989.
   Google Scholar
• LEVIN, H., WILLIAMS, D., EISENBERG, H., et al.: Serial magnetic resonance imaging and neurobe-havioural findings after mild to moderate closed head injury. Journal of Neurology, Neurosurgery and Psychiatry, 55: 255–262, 1992.
   Google Scholar
• VECHT, C. J., VAN WOEKOM, T. C. A. M., TEELKEN, A. W. et al.: Homovanillic acid and 5-hydroxy indoleacetic acid cerebrospinal fluid levels. Archives of Neurology, 32: 792–797, 1975.
   Google Scholar
• FEARLSON, G. D. and ROBINSON, R. G.: Suction lesions of the frontal cerebral cortex in the rat induced asymmetrical behavioral and catechominergic responses. Brain Research, 218: 233–242, 1981.
   Google Scholar
• VAN WOERKOM, T. C., TEELKEN, A. W. MINDERHOUD, J. M., et al.: Difference in neurotransmitter metabolism in frontotemporal love contusion and diffuse cerebral contusion. Lancet, 1: 812–813, 1977.
   Google Scholar
• LEVIN, H. and KRAUS, M. F.: The frontal lobes and traumatic brain injury. Journal of Neuropsychiatry and Clinical Neuroscience, 6: 443–454, 1994.
   Google Scholar
• BROWN, R. M., CRANE, A. M. and GOODMAN, P. S.: Regional distribution of monomaines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synth-esis rates. Brain Research, 168: 133–150, 1979.
   Google Scholar
• WOLFE, N., KATZ, D. I., ALBERT, M. L., et al.: Neuropsychological profile linked to low dopa-mine: in Alzheimer's disease, major depression, and Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 53: 915–917, 1990.
   Google Scholar
• CEDARBAUM, J. M. and McDowELL, F. H.: Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems. In M. D. Yahr and K. J. Bergman (editors) Advances in Neurology (Raven Press, New York), vol. 45, pp. 469–472, 1986.
   Google Scholar
• GILMAN, A. G., RALL T. W. and NIES, A. S. (editors) The Pharmacologic Basis of Therapeutics (Pergamon Press, New York) pp. 466–472, 1990.
   Google Scholar
• HERRMAN, E. C., GRABLIKS, J., ENGLE, C., et al.: Antiviral activity of L-adamantanamine (amantadine). Proc Soc Exp biol Med, 103: 625, 1960.
   Google Scholar
• SCHWAB, R. S., ENGLAND, A. C., FOSTKANZER_, D. C., et al.: Amantadine in the treatment of Parkinson's disease, JAMA, 208: 1168–1170, 1969.
   Google Scholar
• AOKI, F. and SITAR, D.: Clinical pharmacokinetics of amantadine hydrochloride. Clinical Pharmacokinetics, 14: 35–51, 1988.
   Google Scholar
• GIANUTSOS, G., STEWART, C. and DUNN, J. P.: Pharmacologic changes in dopaminergic systems induced by long-term administration of amantadine. European Journal of Pharmacology, 110: 357–61, 1985.
   Google Scholar
• ALLEN, R. M.: Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology. Clinical Neuropharmacology, 6\(suppl. 1): S64-73, 1983.
   Google Scholar
• WELLER, M. and KORNHUBER, J.: A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. Medical Hypostheses, 38: 329–333, 1992.
   Google Scholar
• SCHNEIDEN, H., Cox, B.: A comparison between amantadine and bromocriptine using the stereo-typed behaviour response test (SBR) in the rat. European Journal of Pharmacology, 39: 133–141, 1976.
   Google Scholar
• LAL, S., MERBITZ, C. P. and GRIP, J. C.: Modification of function in head-injured patients with sinemet. Brain Injury, 2: 225–233, 1988.
   Google Scholar
• WOLF, A. P. and GLECKMAN, A. D.: L-dopa/carbidopa and brain injury: funcitonal versus statistical change and suggestions for future research designs. Brain Injury, 9: 487–493, 1995.
   Google Scholar
• GUALTIERI, T., CHANDLER, M., COONS, T. B. and BROWN, L. T.: Amantadine: a new clinical profile for traumatic brain injury. Clinical europharmacology, 12: 258–270, 1989.
   Google Scholar
• VAN REEKUM, R. BAYLEY, M., GARNER, S., et al.: N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Injury. 9: 49–53, 1995.
   Google Scholar
• ANDERSSON, S., BERSTAD, J. FINSET, A., et al.: Amantadine in cognitive failure in patients with traumatic head injuries. Tidsskr Nor laegeforen, 112: 2070–2072, 1992.
   Google Scholar
• NICKELS, J. L., SCHNEIDER, W. N., DOMBOVY, M. L., et al.: Clinical use of amantadine in brain injury rehabilitation. Brain Injury, 8: 709–718, 1994.
   Google Scholar
• HORIGUCHI, J., INAmi, Y. and SHODA, T.: Effects of long term amantadine treatment on clinical symptoms and EEG of a patient in a vegetative state. Clinical Neuropharmacology, 13: 84–88, 1990.
   Google Scholar
• KRAUS, M. F. and MAXI, P. M.: The effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injured patients: case studies and review (in press).
   Google Scholar
• FOLSTEIN, M. F., FOLSTEIN, S. E. and McHuGH, P.: Mini-mental state: a practical method for grading cognitive state of the patient for the clinician. Journal of Psychiatric Research, 12: 189–198, 1985.
   Google Scholar
• ALBERT, M. and COHEN, C.: The test for severe impairment: An instrument of the assessment of patients with severe cognitive dysfunction. Journal of the American Geriatric Society, 40: 449–453, 1992.
   Google Scholar
• SUNDERLAND, T., HILL, J. L., MELLOW, A. M., et al.: Clock drawing in Alzheimer's disease: a novel measure of dementia severity. Journal of the American Geriatric Society, 37: 725–729, 1989.
   Google Scholar
• BRANDT, J.: The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clinical Neuropsychology, 5: 125–142, 1991.
   Google Scholar
• SCITRETLEN, D.: Brief Test of Attention (Author, Baltimore, MD), 1989.
   Google Scholar
• BENTON, A. L.: Differential behavioral effects in frontal lobe disease. Neuropsychologia, 6: 53–60, 1968.
   Google Scholar
• REITAN, R. M. and WOLFSON, D.: The Halstead-Reitan Neuropsychological Test Battery (Neuropsychology Press, Tuscan), 1985.
   Google Scholar
• WECHSLER, D., Wechsler Memory Scale-revised (Psychological Corporation, New York), 1987.
   Google Scholar
• FRITH, C. D., FR_ISTON, K. J., LIDDLE, P. F., et al.: A PET study of word finding. Neuropsychologia, 29: 1137–1148, 1991.
   Google Scholar
• PARKS, R. W., LOEWENSTEIN, D. A., DonkiLL, K. L., et al.: Cerebral metabolic effects of a verbal fluency test: a PET scan study. Journal of Clinical and Experimental Neuropsychology, 10: 565–575, 1988.
   Google Scholar
• REITAN, R. M. and WOLFSON, D.: Category test and trail making test as measures of frontal lobe functions. Clinical Neuropsychology, 9: 50–56, 1995.
   Google Scholar
• WARKENTIN, S. and PASSANT, U. Frontal activation of the frontal lobes: regional cerebral blood flow findings in normals and in patient with frontal lobe dementia performing a word fluency test. Dementia, 4: 188–191, 1993.
   Google Scholar
• FEENEY, D., GONZALES, A. and LAW, W.: Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science, 217: 855–857, 1982.
   Google Scholar
• FEENEY, D. M. and SUTTON, R. L.: Pharmacotherapy for recovery of function after brain injury. CRC Critical Reviews in Neurobiology, 3: 135–197, 1987.
   Google Scholar